MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis
Titel:
MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis
Auteur:
Chan, David W Yung, Mingo MH Chan, Yau-Sang Xuan, Yang Yang, Huijuan Xu, Dakang Zhan, Jin-Biao Chan, Karen KL Ng, Tzi-Bun Ngan, Hextan YS